Search

everythinglearnresearchcommunity

for

Search:↓

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

No definitive link between finasteride and male breast cancer, but further research is needed.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Frequent use of chemical hair relaxers may increase endometrial cancer risk in Black women.

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

More research needed to confirm finasteride as standard treatment for FFA.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

A new compound was effective for imaging prostate cancer in rats.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.